Clearmind reports MEAI intranasal formulation feasibility study success

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. ACN
9. COHR
10. META

Go back to Clearmind reports MEAI intranasal formulation feasibility study success
(NASDAQ: CMND) Delayed: 0.79 -0.01 (1.25%)
Previous Close $0.80    52 Week High $ 
Open $0.79    52 Week Low $ 
Day High $0.80    P/E N/A 
Day Low $0.78    EPS $ 
Volume 122,780